Another pharmaceutical company has stopped testing an experimental drug for COVID-19 due to protection issues. Eli Lilly and Company announced Tuesday that the clinical trial of its antiviral drug opposed to coronaviruses had been suspended through independent monitors “as a precaution”, but without going into detail.
The drug, which Eli Lilly will present with Canadian biotechnology company AbCellera, is part of an elegance of remedies known as monoclonal antibodies, which are designed to act as immune cells that scientists expect to be able to fight the virus. delivered to U. S. President Donald Trump after positive for COVID-19 this month.
The study, presented in August, targeted 10,000 coronavirus patients in the United States. Eli Lilly applied to the US Food and Drug Administration for emergency approval for the drug to be used for mild to moderate cases of COVID-19 infections based on effects from another clinical trial.
A day’s rest, American pharmaceutical company Johnson
The Johnson Vaccine Trial
Advanced testing of this vaccine has resumed in Britain, Brazil, India and South Africa, but are still pending in the United States. The World Bank said Tuesday that it had approved a $12 billion package for upcoming countries to buy and distribute vaccines, tests and remedies. COVID-19.
Meanwhile, the New York Times and The Washington Post claim that Trump’s leadership has followed the strategy of collective immunity as a means to prevent the COVID-19 pandemic. Collective immunity occurs when a population opposes a virus because it has an immunity threshold. reached in that society.
Newspapers say unidentified senior management officials told reporters Monday that they are adopting a strategy to allow coronavirus to spread among healthy youth and protect the elderly and other vulnerable populations to keep the country’s economy moving.
Officials cited a petition titled “The Great Barrington Declaration” published online on October 4, which opposes lockdowns and ignores existing clinical rules on cutting the spread of COVID-19, adding masked dresses, and taking social distance.
The petition states that the strategy, called ‘Targeted Protection’, is’ the ultimate compassionate technique that balances the dangers and benefits of herd immunity. ” The main authors of the strategy are Dr. Scott Atlas, a neurologist who has become one of the main authors of the investigation of President Trump. Top sensible advisers on the pandemic.
The Trump administration’s adoption of collective immunity goes against the World Health Organization’s position that the strategy is unethical. , not exposing others to the virus.
The Netherlands health government said Tuesday that an 89-year-old woman was the first known case of a user who died after contracting COVID-19 for the time being. Researchers recognize that a woman’s immune formula has been weakened through her remedy in a rare form of bone marrow cancer.
The death of woguy coincides with news suggesting that a user inflamed by COVID-19 is still vulnerable to the disease. A report published Monday in the medical journal The Lancet Infectious Diseases found that a 25-year-old boy from Nevada (in the western United States) first tested COVID-19 in April and then a moment in June with more severe symptoms. They took him to get oxygen.
Researchers say the type felt inflamed with two different strains of the new coronavirus, but it also can’t tell why the time of infection got worse. Possibly he would have been exposed to a higher dose of the virus at the time, or the last edition more virulent than the first.